Safety and efficacy of Azithromycin in prevention of chronic obstructive pulmonary disease exacerbation: systematic review | Semantic Scholar
PDF) LONG-TERM AZITHROMYCIN TREATMENT IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Clinical and Safety Outcomes of Long-Term Azithromycin Therapy in Severe COPD Beyond the First Year of Treatment - ScienceDirect
Azithromycin - Wikipedia
Short- and long-term impacts of azithromycin treatment on the gut microbiota in children: A double-blind, randomized, placebo-controlled trial - eBioMedicine
COPD Exacerbations: Should you use long-term azithromycin or roflumilast for care in COPD patients - YouTube
Azithromycin Tablets USP 250mg - Taj Generics Pharmaceuticals | Taj Pharma
Azithromycin: Uses, dosage, side effects, and warnings
Azithromycin side effects and how to avoid them | SingleCare
Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease | Thorax
Respiratory use of long term azithromycin in adults
When guideline treatment of asthma fails, consider a macrolide antibiotic | MDedge Family Medicine
Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial - The Lancet Respiratory Medicine
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial - The Lancet
Meta-Analysis of the Adverse Effects of Long-Term Azithromycin Use in Patients with Chronic Lung Diseases | Antimicrobial Agents and Chemotherapy
Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial - The Lancet Respiratory Medicine
Long-term macrolide treatment for chronic respiratory disease | European Respiratory Society
Mechanism of action, resistance, synergism, and clinical implications of azithromycin - Heidary - 2022 - Journal of Clinical Laboratory Analysis - Wiley Online Library
Cardiovascular Risks with Azithromycin and Other Antibacterial Drugs | NEJM
![PDF] Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/562ad2c017af7c2f6fde4945521ff21cc2c5e818/2-Table1-1.png "PDF] Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis. | Semantic Scholar")
PDF] Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis. | Semantic Scholar
Azithromycin in COPD and GERD | Journal of the COPD Foundation
AZITHROMYCIN
When guideline treatment of asthma fails, consider a macrolide antibiotic | MDedge Family Medicine
